Rise Advisors, LLC Ligand Pharmaceuticals Inc Transaction History
Rise Advisors, LLC
- $220 Million
- Q1 2025
A detailed history of Rise Advisors, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Rise Advisors, LLC holds 84 shares of LGND stock, worth $8,605. This represents 0.0% of its overall portfolio holdings.
Number of Shares
84Holding current value
$8,605% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LGND
# of Institutions
279Shares Held
19MCall Options Held
9.5KPut Options Held
8.1K-
Black Rock Inc. New York, NY2.87MShares$294 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$211 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.03MShares$105 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3906KShares$92.8 Million0.12% of portfolio
-
Dimensional Fund Advisors LP Austin, TX745KShares$76.3 Million0.02% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.73B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...